Table 4

Antibiotic resistance profile of staphylococci from Nigeria
Number (%) of isolates resistant among
Antibiotics MSSA MRSA S. haemolyticus Others (CNS)
n=36 n=15 n=21 n=19
Penicillin 29 (80.6) 15 (100) 21 (100) 18 (94.7)
Oxacillin 0 (0) 15 (100) 21 (100) 12 (63.2)
Teicoplanin 0 (0) 0 (0) 1* (4.8) 0 (0)
Vancomycin 0 (0) 0 (00 0 (0) 0 (0)
Gentamicin 0 (0) 6 (40) 18 (85.7) 9 (47.4)
Tetracycline 21 (58.3) 13 (86.7) 19 (90.5) 9 (47.4)
Ciprofloxacin 2 (5.6) 7 (46.7) 17 (80.9) 9 (47.4)
Moxifloxacin 1 (2.8) 1 (6.7) 6 (28.6) 3 (15.8)
Erythromycin 0 (0) 5 (33.3) 10 (47.6) 0 (0)
Clindamycin 0 (0) 5 (33.3) 5 (23.8) 0 (0)
Fusidic acid 0 (0) 1 (6.7) 1 (4.8) 16 (84.2)
Tigecycline 0 (0) 0 (0) 0 (0) 0 (0)
Mupirocin 0 (0) 0 (0) 0 (0) 0 (0)
Linezolid 0 (0) 0 (0) 0 (0) 0 (0)
Rifampicin 0 (0) 2 (13.3) 4 (19) 0 (0)
Cotrimoxazole 29 (80.6) 13 (86.7) 21 (100) 8 (42.1)

*Intermediate resistance.

Shittu et al.

Shittu et al. BMC Infectious Diseases 2012 12:286   doi:10.1186/1471-2334-12-286

Open Data